Aaron Freidin Sells 8,000 Shares of GRAIL, Inc. (NASDAQ:GRAL) Stock

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) CFO Aaron Freidin sold 8,000 shares of the firm's stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total transaction of $311,440.00. Following the completion of the sale, the chief financial officer owned 286,020 shares in the company, valued at approximately $11,134,758.60. The trade was a 2.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Aaron Freidin also recently made the following trade(s):

• On Friday, May 2nd, Aaron Freidin sold 41,150 shares of GRAIL stock. The stock was sold at an average price of $33.93, for a total value of $1,396,219.50.

GRAIL Stock Performance

Shares of NASDAQ GRAL traded down $0.41 during trading on Monday, reaching $34.79. The company had a trading volume of 211,042 shares, compared to its average volume of 1,156,352. The stock has a market cap of $1.25 billion and a PE ratio of -0.57. The business's 50 day moving average price is $41.81 and its 200-day moving average price is $34.43. GRAIL, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, topping the consensus estimate of ($4.03) by $0.93. The firm had revenue of $31.84 million during the quarter, compared to analysts' expectations of $35.80 million. GRAIL had a negative return on equity of 17.99% and a negative net margin of 1,464.53%. Equities analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group lifted their price objective on GRAIL from $32.00 to $43.00 and gave the company a "buy" rating in a report on Wednesday, May 14th.

Hedge Funds Weigh In On GRAIL

Several institutional investors have recently modified their holdings of the stock. Parallel Advisors LLC raised its stake in GRAIL by 24.1% during the 2nd quarter. Parallel Advisors LLC now owns 2,313 shares of the company's stock worth $119,000 after buying an additional 449 shares during the period. S.A. Mason LLC grew its stake in shares of GRAIL by 50.1% during the 1st quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock worth $38,000 after acquiring an additional 500 shares in the last quarter. Crown Wealth Group LLC increased its position in shares of GRAIL by 5.9% in the second quarter. Crown Wealth Group LLC now owns 8,986 shares of the company's stock valued at $462,000 after acquiring an additional 500 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of GRAIL by 28.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company's stock valued at $76,000 after buying an additional 623 shares during the last quarter. Finally, HighTower Advisors LLC boosted its holdings in shares of GRAIL by 5.7% in the 1st quarter. HighTower Advisors LLC now owns 11,591 shares of the company's stock valued at $296,000 after buying an additional 627 shares during the last quarter.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.